Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Correction: Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma

Bibliographic Details
Main Authors:	Andrew R Conery, Richard C Centore, Adrianne Neiss, Patricia J Keller, Shivangi Joshi, Kerry L Spillane, Peter Sandy, Charlie Hatton, Eneida Pardo, Laura Zawadzke, Archana Bommi-Reddy, Karen E Gascoigne, Barbara M Bryant, Jennifer A Mertz, Robert J Sims III
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2016-07-01
Series:	eLife
Online Access:	https://elifesciences.org/articles/19432

Similar Items

Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma
by: Andrew R Conery, et al.
Published: (2016-01-01)

Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming
by: Ebrahimi, A, et al.
Published: (2019)

Development of selective CBP/P300 benzoxazepine bromodomain inhibitors
by: Popp, T, et al.
Published: (2016)

CBP/p300 bromodomain: new promising epigenetic target
by: Xiang Qiuping, et al.
Published: (2022-01-01)

CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses.
by: Hammitzsch, A, et al.
Published: (2015)

Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains
by: Hay, D, et al.
Published: (2014)

CBP/p300 Bromodomain Inhibitor–I–CBP112 Declines Transcription of the Key ABC Transporters and Sensitizes Cancer Cells to Chemotherapy Drugs
by: Magdalena Strachowska, et al.
Published: (2021-09-01)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
by: Shumei Song, et al.
Published: (2020-06-01)

Generation of a Selective Small Molecule Inhibitor of the CBP/p300 Bromodomain for Leukemia Therapy
by: Picaud, S, et al.
Published: (2015)

CBP/p300 bromodomains regulate amyloid-like protein aggregation upon aberrant lysine acetylation
by: Olzscha, H, et al.
Published: (2016)

The Mode of Stem Cell Division Is Dependent on the Differential Interaction of β-Catenin with the Kat3 Coactivators CBP or p300
by: Agnes I. Lukaszewicz, et al.
Published: (2019-07-01)

Cloning of mouse Cited4, a member of the CITED family p300/CBP-binding transcriptional coactivators: induced expression in mammary epithelial cells.
by: Yahata, T, et al.
Published: (2002)

CREBBP/EP300 bromodomains are critical to sustain the GATA1/MYC regulatory axis in proliferation
by: Veronica Garcia-Carpizo, et al.
Published: (2018-06-01)

Discovery of pyrrolo[3,2-d]pyrimidin-4-one derivatives as a new class of potent and cell-active inhibitors of P300/CBP-associated factor bromodomain
by: Huang, L, et al.
Published: (2019)

Coactivation sign in fixed dystonia.
by: Mehta, A, et al.
Published: (2013)

The bromodomain interaction module.
by: Filippakopoulos, P, et al.
Published: (2012)

The bromodomain interaction module
by: Filippakopoulos, P, et al.
Published: (2012)

Bromodomains as therapeutic targets.
by: Muller, S, et al.
Published: (2011)

Hydrophobic Waters in Bromodomains
by: Serena G. Piticchio, et al.
Published: (2019-08-01)

Selective targeting of bromodomains of the bromodomain-PHD fingers family impairs osteoclast differentiation
by: Meier, JC, et al.
Published: (2017)

Steroid receptor coactivators – their role in immunity
by: Yosi Gilad, et al.
Published: (2022-12-01)

TRIM14 expression is regulated by IRF‐1 and IRF‐2
by: Jingang Cui, et al.
Published: (2019-08-01)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

Selective inhibition of BET bromodomains.
by: Filippakopoulos, P, et al.
Published: (2010)

Spotlight on Plant Bromodomain Proteins
by: Eirini Bardani, et al.
Published: (2023-08-01)

Engineered bromodomains to explore the acetylproteome
by: Del Rosario, Amanda M, et al.
Published: (2016)

An emergent neural coactivity code for dynamic memory
by: El-Gaby, M, et al.
Published: (2021)

Epigenetic mechanisms to propagate histone acetylation by p300/CBP
by: Masaki Kikuchi, et al.
Published: (2023-07-01)

BET bromodomain ligands: Probing the WPF shelf to improve BRD4 bromodomain affinity and metabolic stability
by: Jennings, L, et al.
Published: (2018)

CBP-HSF2 structural and functional interplay in Rubinstein-Taybi neurodevelopmental disorder
by: Aurélie de Thonel, et al.
Published: (2022-11-01)

Heterogeneous fractionation profiles of meta-analytic coactivation networks
by: Laird, A, et al.
Published: (2017)

The race that precedes coactivation: development of multisensory facilitation in children.
by: Barutchu, A, et al.
Published: (2009)

Developing chemical probes for the BET bromodomains
by: Hewings, D, et al.
Published: (2012)

Developing inhibitors of bromodomain-histone interactions
by: Hewings, D
Published: (2014)

Bromodomain-containing proteins in prostate cancer.
by: Urbanucci, A, et al.
Published: (2017)

Development of ligands for the TRIM33 bromodomain
by: See, L
Published: (2018)

Emerging tools to investigate bromodomain functions
by: Kougnassoukou Tchara, P, et al.
Published: (2019)

Bromodomains: are readers right for epigenetic therapy?
by: Conway, S
Published: (2012)

Functional Roles of Bromodomain Proteins in Cancer
by: Samuel P. Boyson, et al.
Published: (2021-07-01)

The Aggregation of ATAD2 Bromodomain in Solution
by: WANG Yuanfang, et al.
Published: (2023-06-01)